Recap: Clearside Biomedical Q4 Earnings

Recap: Clearside Biomedical Q4 Earnings

Clearside Biomedical CLSD reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


Clearside Biomedical beat estimated earnings by 93.75%, reporting an EPS of $0.31 versus an estimate of $0.16.

Revenue was up $25.68 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 1.21% drop in the share price the next day.

Here's a look at Clearside Biomedical's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.08 -0.12 -0.10 -0.11
EPS Actual -0.08 -0.11 -0.13 -0.14
Revenue Estimate 2.58M 690.00K 2.12M 1.29M
Revenue Actual 3.07M 780.00K 34.00K 11.00K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings